Akebia Therapeutics Gross Margin 2013-2025 | AKBA

Current and historical gross margin for Akebia Therapeutics (AKBA) over the last 10 years. The current gross profit margin for Akebia Therapeutics as of September 30, 2025 is %.

Akebia Therapeutics Gross Margin Historical Data
Date	TTM Revenue	TTM Gross Profit	Gross Margin
2025-09-30	$0.22B	$0.18B	79.46%
2025-06-30	$0.20B	$0.15B	75.25%
2025-03-31	$0.18B	$0.13B	68.48%
2024-12-31	$0.16B	$0.10B	60.63%
2024-09-30	$0.17B	$0.11B	64.12%
2024-06-30	$0.18B	$0.11B	62.86%
2024-03-31	$0.19B	$0.12B	65.24%
2023-12-31	$0.19B	$0.12B	62.37%
2023-09-30	$0.19B	$0.14B	72.68%
2023-06-30	$0.20B	$0.13B	63.18%
2023-03-31	$0.27B	$0.20B	72.32%
2022-12-31	$0.29B	$0.21B	70.31%
2022-09-30	$0.30B	$0.16B	53.56%
2022-06-30	$0.30B	$0.18B	61.36%
2022-03-31	$0.22B	$0.07B	32.88%
2021-12-31	$0.21B	$0.06B	28.77%
2021-09-30	$0.21B	$0.03B	12.86%
2021-06-30	$0.22B	$0.03B	13.57%
2021-03-31	$0.26B	$0.06B	23.64%
2020-12-31	$0.29B	$0.11B	38.44%
2020-09-30	$0.31B	$0.17B	54.55%
2020-06-30	$0.34B	$0.19B	54.71%
2020-03-31	$0.35B	$0.22B	62.11%
2019-12-31	$0.34B	$0.19B	56.25%
2019-09-30	$0.33B	$0.22B	66.87%
2019-06-30	$0.29B	$0.22B	75.61%
2019-03-31	$0.24B	$0.20B	86.38%
2018-12-31	$0.21B	$0.21B	100.00%
2018-09-30	$0.24B	$0.24B	100.00%
2018-06-30	$0.23B	$0.23B	100.00%
2018-03-31	$0.21B	$0.21B	100.00%
2017-12-31	$0.18B	$0.18B	100.00%

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$0.364B	$0.160B
Akebia Therapeutics Inc. is a biopharmaceutical company. It focuses on the development and commercialization of proprietary therapeutics based on hypoxia inducible factor biology for patients with kidney disease. Akebia Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$86.784B	32.96
Zoetis (ZTS)	United States	$55.122B	19.73
Takeda Pharmaceutical (TAK)	Japan	$51.166B	10.44
Daiichi Sankyo, - (DSNKY)	Japan	$38.417B	19.13
BeOne Medicines - (ONC)	Switzerland	$37.465B	198.63
Sandoz Group AG (SDZNY)	Switzerland	$34.412B	0.00
United Therapeutics (UTHR)	United States	$20.227B	17.80
Merck (MKKGY)	Germany	$18.999B	11.71
Shionogi (SGIOY)	Japan	$15.585B	14.31
Neurocrine Biosciences (NBIX)	United States	$13.501B	32.40
IPSEN (IPSEY)	France	$13.099B	0.00
Summit Therapeutics (SMMT)	United States	$12.994B	0.00
Ionis Pharmaceuticals (IONS)	United States	$12.867B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$11.287B	0.00
Orion OYJ (ORINY)	Finland	$10.204B	29.15
Eisai (ESAIY)		$8.190B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.967B	21.19
Grifols, S.A (GRFS)	Spain	$6.202B	0.00
Stevanato Group S.p.A (STVN)	Italy	$5.887B	32.95
Crinetics Pharmaceuticals (CRNX)	United States	$5.258B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.547B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.310B	20.46
Indivior (INDV)	United States	$4.123B	16.83
NewAmsterdam Pharma (NAMS)	Netherlands	$3.848B	0.00
Corcept Therapeutics (CORT)	United States	$3.819B	41.26
Centessa Pharmaceuticals (CNTA)	United Kingdom	$3.123B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$2.966B	9.46
Hypermarcas (HYPMY)	Brazil	$2.906B	19.95
Dyne Therapeutics (DYN)	United States	$2.499B	0.00
Ocular Therapeutix (OCUL)	United States	$2.433B	0.00
Soleno Therapeutics (SLNO)	United States	$2.340B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.101B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$1.949B	23.09
Ardelyx (ARDX)	United States	$1.941B	0.00
Guardian Pharmacy Services (GRDN)	United States	$1.858B	35.79
Amylyx Pharmaceuticals (AMLX)	United States	$1.858B	0.00
Harrow (HROW)	United States	$1.745B	107.09
Oruka Therapeutics (ORKA)	United States	$1.668B	0.00
Enliven Therapeutics (ELVN)	United States	$1.615B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.486B	7.36
BioCryst Pharmaceuticals (BCRX)	United States	$1.416B	84.00
Relay Therapeutics (RLAY)	United States	$1.307B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.264B	0.00
Savara (SVRA)	United States	$1.259B	0.00
Evotec AG (EVO)	Germany	$1.243B	0.00
Aktis Oncology (AKTS)	United States	$1.033B	0.00
Theravance Biopharma (TBPH)	United States	$1.032B	43.34
ARS Pharmaceuticals (SPRY)	United States	$1.032B	0.00
Cronos Group (CRON)	Canada	$0.996B	0.00
Xencor (XNCR)	United States	$0.928B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.864B	20.42
KalVista Pharmaceuticals (KALV)	United States	$0.804B	0.00
Nektar Therapeutics (NKTR)	United States	$0.751B	0.00
Esperion Therapeutics (ESPR)	United States	$0.712B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.683B	6.10
Bioventus (BVS)	United States	$0.662B	13.56
ProKidney (PROK)	United States	$0.647B	0.00
Lexeo Therapeutics (LXEO)	United States	$0.528B	0.00
Lyell Immunopharma (LYEL)	United States	$0.512B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.508B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.506B	0.00
Organogenesis (ORGO)	United States	$0.487B	0.00
Altimmune (ALT)	United States	$0.482B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.479B	0.00
Siga Technologies (SIGA)	United States	$0.477B	6.53
4D Molecular Therapeutics (FDMT)	United States	$0.439B	0.00
Nature's Sunshine Products (NATR)	United States	$0.424B	25.24
Aquestive Therapeutics (AQST)	United States	$0.410B	0.00
USANA Health Sciences (USNA)	United States	$0.407B	11.35
Cybin (HELP)	Canada	$0.377B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.300B	0.00
Protara Therapeutics (TARA)	United States	$0.298B	0.00
Avalo Therapeutics (AVTX)	United States	$0.292B	0.00
Profound Medical (PROF)	Canada	$0.290B	0.00
OmniAb (OABI)	United States	$0.289B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.289B	0.00
Relmada Therapeutics (RLMD)	United States	$0.279B	0.00
Larimar Therapeutics (LRMR)	United States	$0.275B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.268B	0.00
Heron Therapeutics (HRTX)	United States	$0.268B	0.00
Fractyl Health (GUTS)	United States	$0.254B	0.00
Journey Medical (DERM)	United States	$0.241B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.233B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.221B	0.00
MediWound (MDWD)	Israel	$0.219B	0.00
Galectin Therapeutics (GALT)	United States	$0.204B	0.00
AleAnna (ANNA)	United States	$0.189B	0.00
Minerva Neurosciences (NERV)	United States	$0.181B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
Century Therapeutics (IPSC)	United States	$0.178B	0.00
Surrozen (SRZN)	United States	$0.164B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.161B	0.00
VAXART, INC (VXRT)	United States	$0.159B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.152B	0.00
Context Therapeutics (CNTX)	United States	$0.151B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.142B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.132B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.124B	0.00
Incannex Healthcare (IXHL)	Australia	$0.123B	0.00
Avita Medical (RCEL)	United States	$0.119B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.116B	0.00
Prelude Therapeutics (PRLD)	United States	$0.114B	0.00
Vivani Medical (VANI)	United States	$0.110B	0.00
Cassava Sciences (SAVA)	United States	$0.105B	0.00
Pyxis Oncology (PYXS)	United States	$0.103B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.102B	0.00
Champions Oncology (CSBR)	United States	$0.098B	41.71
Korro Bio (KRRO)	United States	$0.089B	0.00
Gain Therapeutics (GANX)	United States	$0.076B	0.00
Assertio Holdings (ASRT)	United States	$0.074B	0.00
PolyPid (PYPD)	Israel	$0.073B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.067B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.066B	0.00
Dominari Holdings (DOMH)	United States	$0.066B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.066B	54.75
Rafael Holdings (RFL)	United States	$0.062B	0.00
Metagenomi Therapeutics (MGX)	United States	$0.061B	0.00
ElectroCore (ECOR)	United States	$0.061B	0.00
Arch Biopartners (ACHFF)	Canada	$0.060B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.056B	0.00
Nutriband (NTRB)	United States	$0.054B	0.00
Lipocine (LPCN)	United States	$0.054B	0.00
Lite Strategy (LITS)	United States	$0.049B	0.00
Talphera (TLPH)	United States	$0.047B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.045B	0.00
Plus Therapeutics (PSTV)	United States	$0.041B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.038B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.037B	0.00
Wellgistics Health (WGRX)	United States	$0.036B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.032B	0.00
TherapeuticsMD (TXMD)	United States	$0.029B	0.00
SCYNEXIS (SCYX)	United States	$0.028B	0.00
Natural Alternatives (NAII)	United States	$0.027B	0.00
Klotho Neurosciences (KLTO)	United States	$0.024B	0.00
Scienture Holdings (SCNX)	United States	$0.021B	0.00
Cosmos Health (COSM)	United States	$0.019B	0.00
Traws Pharma (TRAW)	United States	$0.019B	0.02
Liminatus Pharma (LIMN)	United States	$0.019B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Inotiv (NOTV)	United States	$0.019B	0.00
Vivos Therapeutics (VVOS)	United States	$0.017B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.017B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.017B	0.00
Vyome Holdings (HIND)	United States	$0.015B	0.00
Mannatech (MTEX)	United States	$0.014B	0.00
Tempest Therapeutics (TPST)	United States	$0.013B	0.00
BioLineRx (BLRX)	Israel	$0.012B	0.00
CASI Pharmaceuticals (CASI)	China	$0.012B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.011B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.011B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.010B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.010B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.009B	0.00
BioVie (BIVI)	United States	$0.009B	0.00
Mangoceuticals (MGRX)	United States	$0.009B	0.00
Ainos (AIMD)	United States	$0.009B	0.00
Nuvilex (PMCB)	United States	$0.009B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.009B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.009B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.008B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.007B	0.00
Heatwurx (PCSA)	United States	$0.007B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.007B	0.00
Redhill Biopharma (RDHL)	Israel	$0.007B	0.00
Aptorum Group (APM)	United Kingdom	$0.006B	0.00
Indaptus Therapeutics (INDP)	United States	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.006B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
Lyra Therapeutics (LYRA)	United States	$0.004B	0.00
Clearmind Medicine (CMND)	Canada	$0.004B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.003B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Jaguar Animal Health (JAGX)	United States	$0.003B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.001B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00